Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
79.94
-1.72 (-2.11%)
Streaming Delayed Price
Updated: 11:52 AM EST, Mar 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
3
4
5
6
7
8
9
...
67
68
Next >
2 Top Healthcare Stocks to Buy in February
↗
February 26, 2026
Patience should pay off with these two healthcare giants.
Via
The Motley Fool
The Great Reset: UnitedHealth Signals End of Growth Era as 2027 Medicare Rate Shock Looms
February 26, 2026
In a defining moment for the managed care industry, UnitedHealth Group (NYSE: UNH) has signaled a fundamental pivot in its operational philosophy, choosing to prioritize profit margins over its...
Via
MarketMinute
Topics
Economy
The $700 Billion Re-Rating: How the Medicare Advantage ‘Rate Shock’ Ended the Era of Managed Care Excess
February 26, 2026
The managed care sector is reeling from what analysts are calling the "Medicare Advantage Rate Shock," a seismic regulatory shift that has wiped out hundreds of billions of dollars in market...
Via
MarketMinute
Topics
Economy
Government
PBM’s Under Regulatory Attack-Blockchain Upstart WGRX Belongs on Investor’s Radar
February 26, 2026
Via
AB Newswire
The Great Managed Care Reset: UnitedHealth’s 2025 Profit Slump Signals a New Era of Austerity for Medicare Advantage
February 25, 2026
The "golden era" of the managed care sector came to an abrupt and painful halt this year, as UnitedHealth Group (NYSE: UNH) reported a staggering 16% decline in full-year 2025 net profits. This...
Via
MarketMinute
Topics
Earnings
Economy
Uncover the latest developments among S&P500 stocks in today's session.
↗
February 24, 2026
Via
Chartmill
The Great Convergence: How the 'S&P 493' is Finally Stealing the Spotlight from Big Tech
February 24, 2026
As of late February 2026, the U.S. stock market has reached a definitive turning point that many analysts have predicted for years: the era of "narrow leadership" is officially ending. While the S&P...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
What's going on in today's session: S&P500 gap up and gap down stocks
↗
February 24, 2026
Via
Chartmill
The Medicare Rate Shock: Trump Administration’s ‘Flat’ Proposal Triggers Healthcare Market Meltdown
February 24, 2026
The healthcare sector is reeling this February as a series of aggressive regulatory maneuvers from the Trump administration has sent shockwaves through the insurance industry. In what analysts are...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Walgreens Accelerates Restructuring as Sycamore Partners Intensifies Store Closures and Corporate Layoffs
February 23, 2026
DEERFIELD, IL — February 23, 2026 — In a move that underscores the continued volatility of the American retail pharmacy landscape, the newly private Walgreens Boots Alliance has announced a significant...
Via
MarketMinute
High Volatility and Earnings Crossroads: A Deep Dive into Hims & Hers Health (HIMS) in 2026
February 23, 2026
As of February 23, 2026, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself at a critical crossroads that has sent shockwaves through the telehealth and pharmaceutical sectors. Once the darling of the...
Via
Finterra
Topics
Artificial Intelligence
Intellectual Property
Lawsuit
Brightstar Lottery Stock Down 26% as Investor Sells $10 Million in Shares Amid $629 Million Quarter
↗
February 20, 2026
Brightstar Lottery delivers technology and services to regulated lottery markets worldwide, backed by strong recurring revenue streams.
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund's New $14 Million Stake in Cal-Maine Foods Signals Conviction Even as Income Sank 50% Last Quarter
↗
February 20, 2026
Cal-Maine Foods is a leading producer of shell eggs and specialty varieties, serving major retail and foodservice customers nationwide.
Via
The Motley Fool
Topics
Regulatory Compliance
Supply Chain
Braze Stock Down 59%, so Why Did One Fund Just Invest Another $16 Million in Shares?
↗
February 20, 2026
This SaaS provider delivers advanced customer engagement tools for brands seeking data-driven digital marketing solutions worldwide.
Via
The Motley Fool
Topics
Regulatory Compliance
The Resilience of a Healthcare Titan: A Deep Dive into UnitedHealth Group (UNH) in 2026
February 20, 2026
As of February 20, 2026, UnitedHealth Group (NYSE: UNH) finds itself at a historic crossroads. For decades, the Minnetonka-based behemoth was the undisputed gold standard of the healthcare sector—a...
Via
Finterra
Topics
Artificial Intelligence
Retirement
Stocks
US Jobless Claims Data: Labor Market Tightness Persists
February 17, 2026
The latest weekly jobless claims data released this February has painted a picture of a U.S. labor market that remains stubbornly tight, even as cracks begin to show in the broader economic foundation....
Via
MarketMinute
Topics
Economy
Workforce
The Top 5 Analyst Questions From CVS Health’s Q4 Earnings Call
February 17, 2026
CVS Health’s fourth quarter results reflected steady execution across its pharmacy, health services, and insurance businesses, with management crediting improvements in operational efficiency and...
Via
StockStory
Topics
Earnings
Economy
Humana’s 2026 Guidance and the Crisis in Managed Care
February 16, 2026
The managed-care sector faced a brutal reckoning this month as Humana Inc. (NYSE: HUM) unveiled its financial guidance for 2026, signaling a much slower and more painful recovery than investors had...
Via
MarketMinute
Topics
Earnings
Economy
The UnitedHealth Reset: Analyzing the 3.1% Surge and the Future of the Dow’s Healthcare Titan
February 16, 2026
As of February 16, 2026, UnitedHealth Group (NYSE: UNH) finds itself at a historic crossroads. For decades, the Minnesota-based behemoth has been the undisputed bellwether of the American healthcare...
Via
Finterra
Topics
Artificial Intelligence
Economy
Retirement
Kiltearn Partners Exits Sealed Air Position
↗
February 15, 2026
This packaging leader delivers automation and protective solutions to global food, e-commerce, and industrial clients.
Via
The Motley Fool
Topics
Regulatory Compliance
Kiltearn Bought 265,000 LKQ Shares for an $8 Million Bet on the Auto Parts Industry
↗
February 14, 2026
LKQ delivers new and recycled auto parts to repair shops and dealers, serving the aftermarket across North America and Europe.
Via
The Motley Fool
Topics
Regulatory Compliance
Humana’s Star-Crossed Guidance: Why a Q4 Beat Couldn't Save the Stock from a 2026 Tailspin
February 13, 2026
Humana Inc. (NYSE: HUM) sent shockwaves through the managed care sector this week, issuing a 2026 earnings forecast that fell drastically short of Wall Street’s expectations. Despite reporting a...
Via
MarketMinute
Topics
Earnings
Humana Shares Plunge as $3.5 Billion Star Ratings Headwind Forces Conservative 2026 Guidance
February 13, 2026
Humana Inc. (NYSE:HUM) shares experienced a sharp sell-off this week after the health insurance giant issued a surprisingly conservative financial outlook for 2026. The company warned investors that a...
Via
MarketMinute
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
February 12, 2026
As of February 12, 2026, the financial landscape has undergone a tectonic shift, with the healthcare sector decisively seizing the mantle of market leadership. After years of dominance by high-flying...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Healthcare’s Renaissance: Sector Outshines Tech as Policy Clarity Sparks Q4 Surge
February 12, 2026
The healthcare sector has staged a dramatic structural breakout, ending a multi-year period of relative stagnation to lead the global markets into 2026. After a powerful 10% gain in the final quarter...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?
Via
The Motley Fool
Topics
Artificial Intelligence
Humana at the Crossroads: A Deep-Dive into the 2026 Operational Reset
February 11, 2026
As of February 11, 2026, Humana Inc. (NYSE: HUM) finds itself at a historic crossroads. Once the darling of the managed care sector, the Louisville-based insurer is currently navigating a "perfect...
Via
Finterra
Topics
Economy
CVS Health (CVS) Q4 2025 Earnings Call Transcript
↗
February 11, 2026
CVS Health (CVS) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
CVS Q4 Deep Dive: Pharmacy Turnaround and Regulatory Shifts Shape Outlook
February 11, 2026
Diversified healthcare company CVS Health (NYSE:CVS) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 8.2% year on year to $105.7 billion. Its non-GAAP profit of...
Via
StockStory
CVS Health Navigates a Stormy 2026: Record Revenue Tempered by Medicare Advantage Costs and PBM Turmoil
February 10, 2026
In a pivotal earnings report delivered on February 10, 2026, CVS Health (NYSE: CVS) showcased a complex narrative of financial resilience and operational headwinds. While the healthcare giant posted...
Via
MarketMinute
Topics
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
67
68
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.